finance.yahoo.com ·
Corecivic Q1 Earnings Call Highlights
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedCoreCivic, a private prison operator, benefits from increased ICE detention demand, driving occupancy and revenue. The acquisition of Clinical Solutions Pharmacy adds a healthcare revenue stream. Commercial mechanism: demand_spike from government contracts (ICE) and diversification into pharmacy services. Impact is company-specific (CoreCivic) but also signals broader demand for detention capacity and prison healthcare services in the US.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- CoreCivic Q1 2026 adjusted EPS $0.40, adjusted EBITDA $110.1M
- ICE revenue up 96.2% YoY to $128.1M, 58% of total revenue
- Total occupancy 79.6%, average daily population 57,243
- Acquired Clinical Solutions Pharmacy, expected $215M-$230M revenue in 2026
- Raised full-year guidance
Pharmacy acquisition and ICE demand may drive moderate revenue growth over 1-4 weeks; potential for margin improvement exists.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- GLOBAL_HEALTHCAREmid
- REAL_ESTATE_REITSmid